| Description | This product GTTS-WK5890MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the IL-4 protein. This product can be used in -related researches. | This product GTTS-WQ4170MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & Pseudo-UTP. It ecodes the monoclonal antibody that targets LAG3 gene. The antibody can be applied in Solid tumors research. | This product is a 31 kDa recombinant human Clusterin protein Antigen with a N-terminal His6-ABP tag expressed in the E. coli. It is available for Antibody Competition. | Rhesus monkey is widely used in medical and biological research on human and animal related diseases even space travel due to its closeness to the human anatomically and physiologically. This product is isolated from Rhesus monkeys Spleen Tissue. The sample is negative for Herpes-B Virus, as well asRhesus monkey is widely used in medical and biological research on human and animal related diseases even space travel due to its closeness to the human anatomically and physiologically. This product is isolated from Rhesus monkeys Spleen Tissue. The sample is negative for Herpes-B Virus, as well as SRV, SIV, STLV-1, and can be used for a variety of tests and assays such as PCR, Western blot, immunoprecipitation, immunofluorescent flow cytometry.... Read More | The product SIRGT75148WQ is a type of small interfering RNA (siRNA) that targets CIDEB gene and regulates the expression of gene. The siRNA interferes with the expression of CIDEB gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has The product SIRGT75148WQ is a type of small interfering RNA (siRNA) that targets CIDEB gene and regulates the expression of gene. The siRNA interferes with the expression of CIDEB gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More |